Navigation Links
2009 H1N1 vaccine protects against 1918 influenza virus
Date:6/15/2010

Researchers at Mount Sinai School of Medicine have determined people who were vaccinated against the 2009 H1N1 influenza virus may also be protected against the lethal 1918 Spanish influenza virus, which killed more than 50 million people worldwide. The new findings are published in the current issue of Nature Communications.

"While the reconstruction of the formerly extinct Spanish influenza virus was important in helping study other pandemic viruses, it raised some concerns about an accidental lab release or its use as a bioterrorist agent," said Adolfo Garcia-Sastre, PhD, Professor, Microbiology, Mount Sinai School of Medicine, lead investigator on the study. "Our research shows that the 2009 H1N1 influenza vaccine protects against the Spanish influenza virus, an important breakthrough in preventing another devastating pandemic like 1918." Other Mount Sinai School of Medicine groups involved in the study include the laboratories of Dr. Palese and Dr. Basler. The study was also done in collaboration with the group of Dr. Belshe, at St. Louis University, who provided the human vaccination samples.

The researchers administered to three groups of mice either the 2009 H1N1 influenza vaccine, the seasonal influenza vaccine, or no vaccine at all. Twenty-one days later, the mice were exposed to a lethal dose of the 1918 Spanish influenza virus. The mice receiving the H1N1 vaccine were the only ones to survive, while also exhibiting limited morbidity following the vaccination.

Additionally, Dr. Garcia-Sastre's team injected the mice with blood serum taken from humans who had been vaccinated against 2009 H1N1 influenza. Later, the mice were given a potent dose of the 1918 Spanish influenza virus. Researchers found that the antibodies in the blood produced by the 2009 H1N1 vaccine may also protect against the 1918 Spanish influenza virus.

"Considering the millions of people who have already been vaccinated against 2009 H1N1 influenza, cross-protection against the 1918 influenza virus may be widespread. Our research indicates that people who were exposed to the virus may also be protected," said Dr. Garcia-Sastre. "We look forward to conducting further research on the benefits of the 2009 H1N1 influenza vaccine in protecting against the deadly 1918 Spanish influenza virus."


'/>"/>

Contact: Mount Sinai Press Office
newsnow@mountsinai.org
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Related biology news :

1. New discovery could aid development of elusive bovine mastitis vaccine
2. New bacterial signaling molecule could lead to improved vaccines
3. MSU researchers testing vaccine to help people quit smoking
4. New steps toward a universal flu vaccine
5. Cutting-edge vaccine research to be showcased at AAPS National Biotechnology Conference
6. Texas Childrens Hospital vaccine experts present 4 studies
7. Prescription drug could boost effects of vaccines for HIV and other diseases
8. Vaccines preventing pneumococcal disease protect African children with sickle-cell disease
9. GEN reports on the promise of DNA vaccines
10. Researchers use novel nanoparticle vaccine to cure type 1 diabetes in mice
11. Workshop on R&D for rapid vaccine development and production in Asia/Australia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... 2017  Catholic Health Services (CHS) has been ... (HIMSS) Analytics for achieving Stage 6 on the ... In addition, CHS previously earned a place in ... electronic medical record (EMR). "HIMSS Analytics ... EMR usage in an outpatient setting.  This recognition ...
(Date:3/24/2017)... DUBLIN , Mar 24, 2017 Research ... Vehicle Access System Market Analysis & Trends - Industry Forecast to ... ... poised to grow at a CAGR of around 15.1% over the ... This industry report analyzes the market estimates and forecasts for ...
(Date:3/23/2017)... 23, 2017 Research and Markets has announced ... & Trends - Industry Forecast to 2025" report to their ... The ... CAGR of around 8.8% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
Breaking Biology News(10 mins):
(Date:8/23/2017)... Washington, USA, and CARDIFF, UK (PRWEB) , ... ... ... Android tablets that provides neurosurgeons with the ability to manipulate 3D models of ... as “a big step forward” by editors of the Journal of Medical Imaging. ...
(Date:8/23/2017)... ... August 22, 2017 , ... Patients suffering from gum disease and failing implants ... Sawan Malik. Dr. Malik, of Broward Center for Laser Periodontics and Implants ... the future of dentistry with regenerative periodontal procedures. , "I initially ...
(Date:8/23/2017)... ... ... NDA Partners Chairman Carl Peck, MD , announced today that John ... FDA’s Center for Devices and Radiological Health and recognized leader in the medical device, ... to his FDA experience, Dr. Sheets served in senior technical leadership roles in a ...
(Date:8/22/2017)... , ... August 22, 2017 , ... ... in pain management is the practice of opioid-dose sparing. Opioid-dose sparing refers to ... shown promising results, including with non-steroidal anti-inflammatory drugs (NSAIDs). , The potential for ...
Breaking Biology Technology: